A Phase 2 Study of Pembrolizumab Combined with Chemoradiotherapy as Initial Treatment for Anaplastic Thyroid Cancer-Reference-Cited by-同舟云学术

A Phase 2 Study of Pembrolizumab Combined with Chemoradiotherapy as Initial Treatment for Anaplastic Thyroid Cancer

Published:2019-11-01 Issue:11 Volume:29 Page:1615-1622
ISSN:1050-7256
Container-title:Thyroid
language:en
Short-container-title:Thyroid

Author:

Chintakuntlawar Ashish V.¹,Yin Jun²,Foote Robert L.³,Kasperbauer Jan L.⁴,Rivera Michael⁵,Asmus Erik²,Garces Nina I.³,Janus Jeffrey R.⁴,Liu Minetta¹,Ma Daniel J.³,Moore Eric J.⁴,Morris John C.¹⁶,Neben-Wittich Michelle³,Price Daniel L.⁴,Price Katharine A.¹,Ryder Mabel¹⁶,Van Abel Kathryn M.⁴,Hilger Crystal¹,Samb Eleyna¹,Bible Keith C.¹

Affiliation:

1. Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota.

2. Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota.

3. Department of Radiation Oncology and Mayo Clinic, Rochester, Minnesota.

4. Division of Head and Neck Surgery, Mayo Clinic, Rochester, Minnesota.

5. Department of Laboratory and Anatomical Pathology, Mayo Clinic, Rochester, Minnesota.

6. Division of Endocrinology, Mayo Clinic, Rochester, Minnesota.

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link